The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 14,149 | 1,190,000 | SH | SOLE | 1,190,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 4,368 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | 11,468 | 81,000 | SH | SOLE | 81,000 | 0 | 0 | ||
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 12,680 | 478,500 | SH | SOLE | 478,500 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 12,116 | 551,000 | SH | SOLE | 551,000 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 2,131 | 158,000 | SH | SOLE | 158,000 | 0 | 0 | ||
| ATHENEX INC | COM | 04685N103 | 9,356 | 472,500 | SH | SOLE | 472,500 | 0 | 0 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 6,152 | 935,000 | SH | SOLE | 935,000 | 0 | 0 | ||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 11,266 | 437,500 | SH | SOLE | 437,500 | 0 | 0 | ||
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 11,166 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 2,190 | 50,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 2,190 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
| CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 254 | 41,667 | SH | SOLE | 41,667 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 1,210 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 3,721 | 79,000 | SH | SOLE | 79,000 | 0 | 0 | ||
| DANAHER CORPORATION | COM | 235851102 | 1,644 | 11,500 | SH | SOLE | 11,500 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 6,056 | 384,500 | SH | SOLE | 384,500 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 3,121 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 11,149 | 435,500 | SH | SOLE | 435,500 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 59,503 | 2,426,701 | SH | SOLE | 2,426,701 | 0 | 0 | ||
| IRIDEX CORP | COM | 462684101 | 5,329 | 1,171,300 | SH | SOLE | 1,171,300 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 15,692 | 7,617,500 | SH | SOLE | 7,617,500 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,718 | 213,000 | SH | SOLE | 213,000 | 0 | 0 | ||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 9,421 | 347,000 | SH | SOLE | 347,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 6,438 | 62,500 | SH | SOLE | 62,500 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 8,132 | 671,500 | SH | SOLE | 671,500 | 0 | 0 | ||
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 17,542 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
| VERACYTE INC | COM | 92337F107 | 13,728 | 481,500 | SH | SOLE | 481,500 | 0 | 0 | ||
| VIEWRAY INC | COM | 92672L107 | 7,422 | 842,500 | SH | SOLE | 842,500 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,917 | 701,500 | SH | SOLE | 701,500 | 0 | 0 | ||